Best treatments for granulomatosis with polyangiitis
2 products may treat granulomatosis with polyangiitis, spanning FDA drug classes such as cd20-directed cytolytic antibody. The current highest-rated option is riabni. Ranked below by our independent recall-safety rating (rated where FDA data exists) — not medical advice; always consult a professional.
Quick answer: Of the 2 drugs we list for granulomatosis with polyangiitis, none are yet flagged as generics in our price data, spanning classes such as cd20-directed cytolytic antibody. They’re ranked by each drug’s FDA recall-safety record — not clinical effectiveness for granulomatosis with polyangiitis — so confirm the right choice with your prescriber.
Top-rated picks for granulomatosis with polyangiitis: 1. Riabni · 2. Rituxan
| # | Drug | Rating | Type | Form | Class | Generic? | Pharmacy pays | |
|---|---|---|---|---|---|---|---|---|
| 1 | 72/100 | Prescription | Injectable | — | No data | — | View → | |
| 2 | 70/100 | Prescription | Injectable | CD20-directed Cytolytic Antibody | No data | — | View → |
Full ranking · 2 treatments
riabni
Boxed warningPrescriptionFDA-sourced
Riabni (Rituximab-Arrx) is a medication used to treat Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis, B-Cell Lymphoma.
Price varies
rituxan
Boxed warningPrescriptionFDA-sourced
Rituxan (Rituximab) is a cd20-directed cytolytic antibody used to treat Rheumatoid Arthritis, Lymphoid Leukemia, Granulomatosis with Polyangiitis, B-Cell Lymphoma.
Price varies
Frequently asked
- What treats granulomatosis with polyangiitis?
- Our catalog lists 2 products that may treat granulomatosis with polyangiitis, based on NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. They're rated where FDA recall-safety data exists; the current top-rated option is riabni.
- What is the best-rated treatment for granulomatosis with polyangiitis?
- By our independent recall-safety rating — not an efficacy measure — riabni ranks highest among the products we list for granulomatosis with polyangiitis. Always consult a professional.
- How are these treatments ranked?
- By our independent score, currently based on FDA regulatory recall-safety data (the methodology blends additional sources as they come online). See the How we rate page.
- What types of drugs treat granulomatosis with polyangiitis?
- Treatments for granulomatosis with polyangiitis span FDA drug classes including cd20-directed cytolytic antibody. Compare every option side by side, ranked by independent rating, above.
Treatment associations are derived from NIH RxClass (MED-RT “may treat”) drug-classification data — not the verbatim FDA label. This is general reference, not medical advice — always consult a licensed professional.